Spiriva HandiHaler Boehringer Ingelheim - Treatment for Chronic Obstructive Pulmonary Disease (COPD)

Spiriva is an inhaled anticholinergic medication for the long-term, once-daily maintenance treatment of bronchospasm associated with Chronic Obstructive Pulmonary Disease (COPD).

Posted: January 2004

Related Articles:

Spiriva (tiotropium bromide) FDA Approval History

View comments

Hide
(web1)